An orthotopic syngeneic mouse model of bortezomib‐resistant multiple myeloma
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19240 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Manjun Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Multiple Myeloma, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fay Fuller Foundation, National Health and Medical Research Council, Royal Adelaide Hospital Research Fund.
Abstract (Originalsprache)
While bortezomib has significant benefits in multiple myeloma (MM) therapy, the disease remains incurable due to the invariable development of bortezomib resistance. This emphasises the need for advanced models for preclinical evaluation of new therapeutic approaches for bortezomib‐resistant MM. Here, we describe the development of an orthotopic syngeneic bortezomib‐resistant MM mouse model based on the most well‐characterised syngeneic MM mouse model derived from spontaneous MM‐forming C57BL/KaLwRij mice. Using bortezomib‐resistant 5TGM1 cells, we report and characterise a robust syngeneic mouse model of bortezomib‐resistant MM that is well suited to the evaluation of new therapeutic approaches for proteasome inhibitor‐resistant MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.
- Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
- Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
- School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia.
ORCID-Profile: Manjun Li, Melissa K Bennett, John Toubia, Victoria S Pope, Melinda N Tea, Michael S Samuel, Paul H Anderson, Briony L Gliddon, Jason A Powell, Stuart M Pitson
Förderung
- Fay Fuller Foundation
- National Health and Medical Research Council
- Royal Adelaide Hospital Research Fund
- Australian Government Research Training Program Scholarship
Zitieren
APA
Li, M., Bennett, M. K., Toubia, J., Pope, V. S., Tea, M. N., Tamang, S., Samuel, M. S., Anderson, P. H., Gliddon, B. L., Powell, J. A., & Pitson, S. M. (2024). An orthotopic syngeneic mouse model of bortezomib‐resistant multiple myeloma. British Journal of Haematology. https://doi.org/10.1111/bjh.19240
Vancouver
Li M, Bennett MK, Toubia J, Pope VS, Tea MN, Tamang S, et al. An orthotopic syngeneic mouse model of bortezomib‐resistant multiple myeloma. British Journal of Haematology. 2024. doi:10.1111/bjh.19240
BibTeX
@article{Li2024,
author = {Li, Manjun and Bennett, Melissa K and Toubia, John and Pope, Victoria S and Tea, Melinda N and Tamang, Sarah and Samuel, Michael S and Anderson, Paul H and Gliddon, Briony L and Powell, Jason A and Pitson, Stuart M},
title = {An orthotopic syngeneic mouse model of bortezomib‐resistant multiple myeloma},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19240}
}
EUVIMED